RAB11A and early-onset autosomal dominant Alzheimer disease: Furthermore, Rab11A has been associated with neurodegenerative pathologies like Parkinson’s and Alzheimer’s diseases featuring as an important regulator for the trafficking of both alfa-synuclein [45] or Aβ [46] arising during the development of these diseases.